National Oxygen Intrinsic Value
National Oxygen (NOL) median intrinsic value is ₹29.12 from 5 valuation models (range ₹22–₹44), vs current price ₹54.75 — -46.8% downside (Trading Above Calculated Value), margin of safety -88.0%. For current market price and key ratios, visit National Oxygen share price chart.
NOL Valuation Methods Summary — DCF, Graham Number & P/E
National Oxygen intrinsic value across 5 models vs current price ₹54.75 — upside/downside and value range per method. Read NOL dividend history for the complete payout history and dividend yield track record.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹43.68 | ₹34.94 - ₹52.42 | -20.2% | EPS: ₹3.64, Sector P/E: 12x |
| Revenue Multiple Method | revenue | ₹36.80 | ₹33.12 - ₹40.48 | -32.8% | Revenue/Share: ₹46.00, P/S: 0.8x |
| Simple DCF (5Y) | dcf | ₹21.90 | ₹17.52 - ₹26.28 | -60.0% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹23.30 | ₹20.97 - ₹25.63 | -57.4% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹29.12 | ₹26.21 - ₹32.03 | -46.8% | Revenue Growth: -18.4%, Adj P/E: 8.0x |
NOL Intrinsic Value vs Market Price — All Valuation Models
National Oxygen fair value range ₹22–₹44 vs current market price ₹54.75 across 5 valuation models. Analyse National Oxygen ownership pattern to track promoter, FII and institutional holdings.
NOL Intrinsic Value Analysis — Undervalued or Overvalued?
National Oxygen median intrinsic value ₹29.12, current price ₹54.75 — Trading Above Calculated Value by 46.8%, margin of safety -88.0%.
What is the intrinsic value of NOL?
Based on our comprehensive analysis using 5 different valuation methods, the estimated intrinsic value of National Oxygen (NOL) is ₹29.12 (median value). With the current market price of ₹54.75, this represents a -46.8% variance from our estimated fair value.
The valuation range spans from ₹21.90 to ₹43.68, indicating ₹21.90 - ₹43.68.
Is NOL undervalued or overvalued?
Based on our multi-method analysis, National Oxygen (NOL) appears to be trading above calculated value by approximately 46.8%.
NOL Financial Health — Key Ratios vs Industry Benchmarks
National Oxygen financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 0.17 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Return on Equity | -33.3% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | -14.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.82x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
NOL Cash Flow Quality — Operating & Free Cash Flow
National Oxygen operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹1 Cr | ₹-1 Cr | Positive Operating Cash Flow | 6/10 |
| March 2023 | ₹2 Cr | ₹2 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹12 Cr | ₹12 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹7 Cr | ₹7 Cr | Positive Free Cash Flow | 8/10 |